SRPT

Sarepta Therapeutics, Inc. News Headlines

$13.8
*  
0.30
2.22%
Get SRPT Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SRPT Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Commit To Buy Sarepta Therapeutics At $18, Earn 27.7% Annualized Using Options
7/10/2014 10:55:11 AM - BNK Invest


Pre-Market Most Active for Jul 10, 2014 : CBSO, ALU, CBS, MT, BAC, TVIX, AAPL, FB, QQQ, BCS, MEMP, SRPT
7/10/2014 7:39:57 AM - NASDAQ.com News


Sarepta Therapeutics (SRPT) Enters Oversold Territory - Tale of the Tape
7/8/2014 7:05:23 AM - Zacks.com


SRPT Crosses Below Key Moving Average Level
6/25/2014 11:00:52 AM - BNK Invest


Short Interest is Piling Up in Sarepta Therapeutics (SRPT) Stock, Time to Panic? - Tale of the Tape
6/24/2014 8:09:29 AM - Zacks.com


Small Advances for Healthcare Stocks; PTC Therapeutics Rallies After Duchenne Muscular Dystrophy Drug Approved
5/23/2014 12:15:46 PM - MT Newswires


Sector Update: Healthcare
5/23/2014 12:07:27 PM - MT Newswires


Sector Update: Healthcare Shares Mixed; Vertex Up 6% on Positive Coverage
5/22/2014 2:53:12 PM - MT Newswires


Sector Update: Healthcare
5/22/2014 2:50:23 PM - MT Newswires


Why I Have Re-Entered Sarepta Therapeutics
5/7/2014 11:25:00 AM - Seeking Alpha


Notable ETF Inflow Detected - XBI, SRPT, MYGN, MNKD
5/7/2014 10:01:30 AM - BNK Invest


Noteworthy ETF Outflows: XBI, SRPT, MNKD, RGEN
4/28/2014 9:58:55 AM - BNK Invest


Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog
4/22/2014 3:45:01 PM - Zacks.com


SRPT Crosses Above Key Moving Average Level
4/21/2014 10:41:53 AM - BNK Invest


U.S. Stock Futures Mixed Before Open as Investors Sift Through Earnings
4/21/2014 8:13:33 AM - MT Newswires


U.S. Stock Futures Edge Higher; Companies Report Mixed Earnings
4/21/2014 7:50:43 AM - MT Newswires


Pre-Market Most Active for Apr 21, 2014 : NMR, SRPT, AMD, NEM, ABX, FB, AZN, MU, JASO, BAC, WB, CBEY
4/21/2014 7:39:52 AM - NASDAQ.com News


Sector Update: Health Care
4/21/2014 7:22:04 AM - MT Newswires


Sector Update: Health-Care Shares Flat Pre-Market; Sarepta Soars 75% on New Drug Application Plans for Eteplirsen
4/21/2014 7:18:57 AM - MT Newswires


Why Now Is The Time To Get Behind Sarepta Therapeutics
4/1/2014 2:41:00 AM - Seeking Alpha


Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha


Prosensa Rises on Encouraging Data - Analyst Blog
3/19/2014 4:20:01 PM - Zacks.com


On Sarepta's 2013 Results And Upcoming Events
3/4/2014 9:57:00 AM - Seeking Alpha


Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting Endpoints
2/27/2014 8:26:00 AM - MT Newswires


Sector Update: Healthcare
2/27/2014 8:22:40 AM - MT Newswires